Posted in Clinical Trials, Diabetes News • Tags: Clinical Trials, Qnexa
Qnexa is a new drug targeted at diabetes from VIVUS, currently undergoing clinical trials.
Basically Qnexa is combination of phentermine and an epilepsy drug Topamax (also used for migraines) .
From the VIVUS site:
More →
Posted on August 6, 2008 by Tina Radcliffe • There are 2 comments!